학술논문
The impact of dapagliflozin on HbA1c , systolic blood pressure and weight: a review of dapagliflozin use in a Scottish city.
Document Type
Academic Journal
Source
Subject
Language
English
ISSN
2047-2897
Abstract
We aimed to determine the efficacy of dapagliflozin in the management of type 2 diabetes in a Scottish population through measurements of glycaemic control, blood pressure and weight. Dapagliflozin was effective in improving HbA1c by 10 mmol/mol ( SE 1.8, p < 0.001), systolic blood pressure by 9. 8mmHg ( SE 2.2, p < 0.001) and weight by 3.2 kg ( SE 0.6, p < 0.001). There was a significant proportion of people with diabetes who reported side effects with dapagliflozin relating to genital and urinary tract infections. Dapagliflozin appears to be an effective drug in improving HbA1c , systolic blood pressure and weight in people with type 2 diabetes. However, in this cohort a substantial proportion of people with diabetes did not tolerate this drug due to side effects. Copyright © 2017 John Wiley & Sons.